EP300 and skin squamous cell carcinoma: Given the established tumor suppressor role of the DDR and its other targets, it is not surprising that p300 mutations are associated with tumorigenesis and act as a tumor suppressor in cutaneous squamous cell carcinoma (cSCC) [52].